Arno Therapeutics
About:
Arno Therapeutics is a biopharmaceutical company developing innovative products for the treatment of cancer patients.
Website: http://www.arnothera.com
Top Investors: Perceptive Advisors, OPKO Health, Soros Fund Management, Pontifax, Commercial Capital LLC
Description:
Arno Therapeutics is a biopharmaceutical company focused on creating value through the development of innovative products for the treatment of cancer patients.
Total Funding Amount:
$61.4M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Parsippany, New Jersey, United States
Founded Date:
2000-01-01
Contact Email:
info(AT)arnothera.com
Founders:
David M. Tanen
Number of Employees:
11-50
Last Funding Date:
2016-08-16
IPO Status:
Public
Industries:
© 2025 bioDAO.ai